excited for May awareness for #bladdercancer honored to serve mutual mission with Bladder Cancer Advocacy Network joined by Jonathan L Wright patient advocates, survivors, community! Join us for annual walk on May 18:

secure2.convio.net/bcani/site/TR/…

Ali Khaki Brian Lawenda MD OncoAlert Sarah P. Psutka MD MS Carissa Chu

Get ready to dive into the latest and greatest in oncology at #ASCO24 , coming up in just a month! 🎉 Reserve your seat now and join the excitement! 🔬💥bit.ly/4deoX4y #oncology #CME OncoAlert OncLive.com CancerNetwork®

Don't miss the OncoAlert newsletter!! 🧬🦋☢️ ⬇️⬇️⬇️
#OncoAlertAF

Newsletter by OncoAlert !
#OncoAlertAF

A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell carcinoma. Clinical Cancer Research #oncology OncoAlert OncoDaily #CCRCC

OPEN ACCESS:
aacrjournals.org/clincancerres/…

Excited to start day 2 of Advanced Prostate Cancer Consensus Conference OncoAlert

Medscape Oncologist Burnout & Depression Report 2024: 'We Have Much Work to Do'

💥Oncology ranks in the top 3

💥Female oncologists experience more burnout than males.

💥The main reasons are bureaucratic tasks and workload intensity.

Suggested solutions?

OncoAlert…

USPSTF Recommendation: Screening for Breast Cancer

💥The USPSTF recommends biennial screening mammography for women aged 40 to 74 years.

💥For those aged 75 and over, the evidence is insufficient

OncoAlert JAMA
jamanetwork.com/journals/jama/…

#APCCC2024 Advanced Prostate Cancer Consensus Conference the main question remains unanswered triple therapy or doublet therapy in mSCPC, more biomarkers are needed, clinical variables should orientate nowadays treatment OncoAlert OncoReporte UroToday.com Uromigos outstanding presentation by Nick James 🦾

The OncoAlert 🚨Network Warmly extends its congratulations to Two of our Distinguished Faculty, part of our Founding faculty and ESMO - Eur. Oncology Presidents:

⚕️ Solange Peters 🇨🇭 from CHUV / Centre hospitalier universitaire vaudois
⚕️ FabriceAndre 🇫🇷 from Gustave Roussy

Named Giants of Cancer Care, an award that

Is bilateral oophorectomy associated with a decreased risk of death among women with a BRCA1 or BRCA2 🧬sequence variation❓
➡️ In this cohort study oophorectomy was associated with a significant reduction in all-cause mortality📉‼️ OncoAlert #OncoAlertAF

HERE IN #APCCC24 🇨🇭
IT'S ALL ABOUT THAT PSMA

Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin Neeraj Agarwal, MD, FASCO Ravindran Kanesvaran Simon C
Eleni Efstathiou Dra. María Natalia Gandur Quiroga A/Prof. Shahneen Sandhu
Christopher Sweeney, MBBS Daniel E Spratt Howard Soule
neal shore Robert Reiter Dana Rathkopf
Colin Pritchard…

⏰NOW OUT‼️ #ASCO24 Abstract Titles
🔥Clinical Science Symposium: Targeting KRAS in NSCLC
☑️ #LBA8509 KRYSTAL-12 Tony Mok
☑️#8510 Olomorasib + Pembro @TimBurns MD,PHD
☑️ #LBA8511 KROCUS Fulzerasib Dr.Vanesa Gregorc
☑️#8512 CodeBreaK 101 Dr.Bob T. Li
and others
#LCSM OncoAlert ASCO

Great talk by prof. Barbara Jereczek-Fossa on the role of salvage RT in BCR #APCCC24 GU Cast | Urology podcast! OncoAlert Advanced Prostate Cancer Consensus Conference

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉Future of mHSPC #ProstateCancer treatment by AttardLab 👉Biomarkers based strategies will play a major role for Rx selection including docetaxel 👇OncoAlert PCF Science UroToday.com

Thank you so much OncoAlert for highlighting.

Dear Colleagues,
One Month until #ASCO24 🌐
WE ARE READY
WE ARE OncoAlert 🚨

#OncoAlertAF
Dra. María Natalia Gandur Quiroga 🇦🇷
Alizée Camps - - Maléa 🇫🇷
Marta Perachino 🇮🇹
Kathrin Heinrich 🇩🇪
Biagio Ricciuti, MD PhD 🇺🇸
Deniz Can Guven 🇹🇷
Emre Yekedüz 🇺🇸
Hidehito HORINOUCHI 🇯🇵
Fadi Haddad, MD 🇺🇸
Dr. Iván R. González 🇲🇽…

New MASCC-ASCO standards aim to standardize quality survivorship care for those with advanced/metastatic cancer, addressing unique challenges and care goals focusing on 7 key areas to ensure patient-centered, coordinated, and accessible care!
ASCO MASCC @oncoalert…

Newsletter OncoAlert is out 👋🏻